Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,135 | -10,221 | -3,713 | -116 | 0 |
| Depreciation Amortization | 44 | 42 | 1 | N/A | 0 |
| Accounts payable and accrued liabilities | -74 | -126 | 336 | 59 | N/A |
| Other Working Capital | -324 | 244 | 398 | 59 | 0 |
| Other Operating Activity | 1,675 | 2,100 | -11 | -59 | 0 |
| Operating Cash Flow | $-7,814 | $-7,961 | $-2,988 | $-57 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -76 | -289 | -94 | N/A | 0 |
| Net Acquisitions | 71 | N/A | N/A | N/A | 0 |
| Investing Cash Flow | $-5 | $-289 | $-94 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -58 | N/A | -24 | -2 | N/A |
| Common Stock Issued | 10,000 | N/A | 15,405 | 1 | N/A |
| Other Financing Activity | -1,486 | 0 | -1,883 | 481 | 0 |
| Financing Cash Flow | $8,456 | $0 | $13,498 | $480 | $0 |
| Beginning Cash Position | 2,591 | 10,840 | 424 | 2 | 0 |
| End Cash Position | 3,227 | 2,591 | 10,840 | 424 | 0 |
| Net Cash Flow | $636 | $-8,250 | $10,416 | $422 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,814 | -7,961 | -2,988 | -57 | 0 |
| Capital Expenditure | -76 | -289 | -94 | N/A | N/A |
| Free Cash Flow | -7,891 | -8,250 | -3,082 | -57 | 0 |